Skip to main navigation Skip to search Skip to main content

Triplet regimen with camrelizumab plus apatinib in combination with hepatic artery infusion chemotherapy (HAIC): a new treatment paradigm for select patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinomry infusion chemotherapy (HAIC): a new treatment paradigm for select patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma?

Research output: Contribution to journal › Editorial

Original languageEnglish
Pages (from-to)80
Number of pages1
JournalChinese Clinical Oncology
Volume13
Issue number5
DOIs
StatePublished - Oct 31 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Hepatocellular carcinoma (HCC)
  • antiangiogenic
  • hepatic artery infusion chemotherapy
  • immunotherapy

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Triplet regimen with camrelizumab plus apatinib in combination with hepatic artery infusion chemotherapy (HAIC): a new treatment paradigm for select patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinomry infusion chemotherapy (HAIC): a new treatment paradigm for select patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma?'. Together they form a unique fingerprint.

Cite this